Abiraterone and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post Chemotherapy- An Indirect Comparison and Budget Impact Analysis
Abstract
Authors
T. Li M. Thompson M. Todd M. Yu T. Kheoh R. Saadi